Important factors that could change actual, future results include: changes in sales levels to our largest customers, weather patterns in Hawaii, production problems, risks associated with new products, foreign exchange fluctuations, and availability of financing, as well as national and global political, economic, business, competitive, market and regulatory conditions. Cyanotech Corporation 73-4460 Queen Kaahumanu Hwy. Cyanotech Corp (CYAN) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, March 31, 2010 (310) 346-6131, Q3 FY2022 Investor Call Script as recorded, *NEW* BioAstin Water Dispersible Astaxanthin, Cyanotech Reports Financial Results for the First Quarter of Fiscal 2023, Q4 and Fiscal Year 2022 Earnings Broadcast. Show More Cyanotech Demographics. Cyanotech Corporation 73-4460 Queen Kaahumanu Hwy. Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the first quarter of fiscal year 2021, ended June 30, 2020 . Forward-looking statements relate to the future and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our Business Information Report Snapshot is a collection of business credit scores and ratings that help you gauge the financial health of your customers, suppliers, and business partners Access the company's payment history and background information on key employees Operating income was $228,000 compared to operating loss of ($1,321,000) in the fourth quarter of fiscal 2019. Commenting on the third quarter fiscal 2022 results, Cyanotechs Chief Executive Officer, Gerald R. Cysewski, Ph.D., said: In the third quarter, we were able to produce consistent results even as we contend with the same range of supply chain constraints facing most production and manufacturing businesses. In addition, all three of our loan and debt covenants with the bank were in compliance as of the end of the fiscal year.. The Company will respond only to relevant questions relating to the Companys fourth quarter and fiscal 2020 financial performance and will not be accepting any questions or comments during the broadcast. Cyanotech shares outstanding from 2010 to 2022. Interested parties are asked to submit questions to [emailprotected] before 12 p.m. EDT on Wednesday, June 24, 2020. Operating income was $1,053,000 compared to operating loss of ($2,997,000). Fiscal Year 2021 Cyanotech reported net sales of $32,345,000 for fiscal 2021 compared to $31,899,000 in fiscal 2020, an increase of 1.4%. Net income was $387,000, or $0.06 per diluted share, compared to net loss of ($3,596,000), or ($0.62) per diluted share. Providing further detail about the fiscal results, Cyanotechs Chief Financial Officer, Brian Orlopp, added, Net sales increased 5.6% to $31,899,000 in fiscal 2020 as compared with fiscal 2019, driven by a 68.0% increase in astaxanthin and spirulina bulk sales and an increase in contract extraction sales, partially offset by a 3.2% decrease in packaged sales from the prior year. We work together as a company with respect, doing our best for each other, for our customers, and for the planet. Contact Us. KAILUA KONA, Hawaii, November 10, 2021--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2022 Annual Reports. Operating income for the first nine months of fiscal 2022 was $2,210,000 compared to $109,000 in the same period of the prior year. Quarterly Reports. Cyanotech Corporation (NASDAQ:CYAN) August 11, 2022; 8:00PM EDT Executives: Matt Custer President and Chief Executive Officer Felicia Ladin Chief Financial Officer Matt: Aloha KAILUA KONA, Hawaii (August 10, 2022) Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, Cyanotech Corporation (NASDAQ:CYAN) Q4 and Fiscal Year 2022 Earnings Broadcast January 23, 2022; 8:00PM EDT Executives: Gerry Cysewski Chief Executive Officer Emeritus Matthew Custer KAILUA KONA, Hawaii (June 22, 2022) Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, Cyanotech Corporation (NASDAQ:CYAN) Q3 Fiscal Year 2022 Earnings Broadcast February 11, 2022; 8:00PM EDT Executives: Gerry Cysewski Chief Executive Officer Felicia Ladin Chief KAILUA KONA, Hawaii Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results November 11, 2021; 8:00PM EDT Executives: Gerry Cysewski Chief Executive Officer Felicia Ladin Chief Financial Officer Gerry Cysewski Aloha from Kona, Hawaii. Suite #102 Safe Harbor Statement under the U.S. This product is not intended to diagnose, treat, cure or prevent any disease. Suite #102 Kailua-Kona, HI 96740. Cyanotech reported net sales of $31,899,000 for fiscal 2020 compared to $30,202,000 in fiscal 2019. Private Securities Litigation Reform Act of 1995 Besides statements of present fact and historical fact, this press release may contain forward-looking statements. Operating income was $49,000 compared to operating loss of ($1,167,000). Our actual results may differ materially from those contemplated by forward-looking statements. Gross profit was $2,894,000 . Viewing insider transactions for Cyanotech Corporation's (NASDAQ:CYAN ) over the last year, we see that insiders were net buyers. This metric excludes the company's treasury shares. All Cyanotech products are produced from microalgae grown at our 96-acre facility in Kona, Hawaii using patented and proprietary technology and are Generally Recognized as Safe (GRAS) for use in food products. The average employee at Cyanotech makes $48,609 per year. CYANOTECH CORP Files SEC form 10-K, Annual Report. Please review the Companys Form 10-Q for the period ended December 31, 2021 for more detailed information. SEC Filings. Cyanotechs Spirulina products offer nutrition that supports cardiovascular health and immunity. Cyanotech Corporation is incorporated in Nevada. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. Gross profit was $13,442,000, with gross profit margin of 36.1%, compared to $11,431,000 and 36.2%. 2016 Annual Report for . Cyanotech Reports Financial Results for the First Quarter of Fiscal 2022. . 2019 ANNUAL REPORT CORPORATE HEADQUARTERS Cyanotech Corporation 73-4460 Queen Kaahumanu Hwy, Suite 102 Keahole Point Kailua-Kona, Hawaii 96740 t (808) 326-1353 | f (808) 329-3597 cyanotech.com WHOLLY OWNED SUBSIDIARY Nutrex-Hawaii, Inc. CYANOTECH CORPORATION 2019 ANNUAL REPORT Phone (800) 395-1353 or (808) 326-1353 CYAN: Cyanotech broker reports. 3 November 2022 SEE EVENTS Report Our 2021 Annual Report Read our latest Annual Report, including Glanbia ESG Board Committee report, ESG performance highlights, and TCFD disclosure Download Reasons to invest A broad portfolio, continuously strong performance and a proven strategy for growth. City Charter 2603 (i) requires the Board to prepare an annual report each year, including a summary of the Board's activities, education and training conducted, complaints received, enforcement actions resolved, advice provided, rules promulgated, and legislative recommendations as appropriate. Operating income was $1,053,000 compared to operating loss of ($2,997,000). Cyanotech is a microalgae-based heath product producing company that offers Hawaiian Spirulina Pacifica and BioAstin Hawaiian Astaxanthin. Gross profit was $11,117,000, with gross profit margin of. Cyanotech Corporation The Company is regulated by the Food and Drug Administration. Click the button below to request a report when hardcopies become available. Click the button below to request a report when hardcopies become available. (tm) programs, which include the Annual Reports Service, the Fund Info Service . Thank KAILUA KONA, Hawaii (November 10, 2021) Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, *NEW* BioAstin Water Dispersible Astaxanthin, Cyanotech Reports Financial Results for the First Quarter of Fiscal 2023, Q4 and Fiscal Year 2022 Earnings Broadcast, Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2022, Q3 FY2022 Investor Call Script as recorded, Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022, Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2022. Important factors that could change actual, future results include: changes in sales levels to our largest customers, weather patterns in Hawaii, production problems, risks associated with new products, foreign exchange fluctuations, and availability of financing, as well as national and global political, economic, business, competitive, market and regulatory conditions. Request Information The Company will respond only to relevant questions relating to the Companys third quarter fiscal 2022 financial performance and will not be accepting any questions or comments during the broadcast. For the Fiscal Year Ended March 31, 201 8 . Cyanotech reported net sales of $8,071,000 for the first quarter of fiscal 2020 compared to $7,145,000 for the first quarter of fiscal 2019. This means that a larger number of shares were purchased by insiders in relation to shares sold. Gross profit was $3,238,000, with gross profit margin of 34.2%, compared to gross profit of $2,071,000, with gross profit margin of 29.6%. The Company is following all state and local mandates and is taking preventive measures to ensure the safety of our workforce. Cyanotech reported net sales of $9,438,000 for the fourth quarter of fiscal year 2021 compared to $8,634,000 in the fourth quarter of fiscal 2020, an increase of 9.3%. Below are links to those reports. Third Quarter Fiscal 2022 Bruce Russell: [emailprotected] End of Day Stock Quote. Gross profit was $3,238,000,. CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada . Contact Us: [emailprotected], Media & Investors Safe Harbor Statement under the U.S. All News. Cyanotech reported net sales of $9,459,000 for the third quarter of fiscal 2022 compared to $6,985,000 for the third quarter of fiscal 2021, an increase of 35.4%. Quarter over quarter net sales for fiscal 2020 have been consistent and have allowed us to improve cash management culminating in significant accounts payable reduction, balancing inventory levels and building cash reserves., The COVID-19 pandemic has caused volatility in global markets. News. Hawaiian Stilt (Himantopus mexicanus knudseni) Prepared by J. Scott Waddington . Cyanotech Corp (CYAN) SEC Filing 10-K Annual report for the fiscal year ending Sunday, March 31, 2019. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ANNUAL REPO. Phone (800) 395-1353 or (808) 326-1353 . Visit www.cyanotech.com for more information. Cyanotech reported net sales of $6,716,000 for the first quarter of fiscal 2023 compared to $8,964,000 for the first quarter of fiscal 2022, a decrease of 25.1%. For the trailing twelve months ended December 31, 2021, compared to the trailing twelve months ended December 31, 2020, net sales were $37,280,000 compared to $31,541,000. Get the latest broker reports from Zacks Investment Research. For the Fiscal Year Ended March 31, 2022 . 51-200 Employees Based in kailua-kona, Hawaii Most Recent Annual Report MOST RECENT 2021 Annual Report and Form 10K View PDF View Form 10K (HTML) Cyanotech Corporation does not currently have any hardcopy reports on AnnualReports.com. Please fill out the form below and click "Place Order" to complete your order. Cyanotech Corporation 73-4460 Queen Kaahumanu Hwy. Cyanotech Corporation does not currently have any hardcopy reports on AnnualReports.com. To join the broadcast, please browse http://cyanotech.com/meet approximately five minutes prior to the start time. Bruce Russell: [emailprotected] KAILUA KONA, Hawaii--(BUSINESS WIRE)-- Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2022, ended June 30, 2021.First Quarter Fiscal 2022. Our principal executive offices are located at 73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, Hawaii 96740, and our telephone number is (808) 326-1353. Operating income for the third quarter of fiscal 2022 was $508,000 compared to operating loss of $441,000 in the same period of the prior year. The Companys mission is to fulfill the promise of whole health through Hawaiian microalgae. The prior trailing twelve months ended December 31, 2020 included the forgiveness of the loan under the Paycheck Protection Program in the amount of $1,389,000. The companys products include BioAstin natural astaxanthin, a dietary antioxidant for use as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, as well as to enhance skin, eye, and joint health. 2022 Annual Report: 2022 Proxy Statement: 2021 Annual Report: 2021 Proxy Statement: 2020 Annual Report: 2020 Proxy Statement: Public Filings. Cyanotech reported net sales of $6,716,000 for the first quarter of fiscal 2023 compared to $8,964,000 for the first quarter of fiscal 2022, a decrease of 25.1%. Cyanotech has 4 employees at their 1 location and $35.97 m in annual revenue in FY 2022. View as % YoY growth or as % of revenue. Cyanotech Corporation Cyanotech will host a Skype broadcast at 8:00 PM EDT on Wednesday, June 24, 2020to respond to questions about its operating results and other topics of interest. Suite #102 Kailua-Kona, HI 96740. Fax (808) 329-4533 2020 Annual Report. Financial Tables Follow: The following tables do not contain footnotes or other information contained in the Companys Form 10-K for the fiscal year ended March 31, 2020, which can be found on the Cyanotech website (www.cyanotech.com) under Investors>Investor Filings upon filing. Cyanotech Fast Facts. Kailua-Kona, HI 96740, Phone (800) 395-1353 or (808) 326-1353 73-4460 Queen Kaahumanu Hwy. Please review the Companys Form 10-K for the period ended March 31, 2020 for more detailed information. 73-4460 Queen Kaahumanu Hwy. Q4 and Fiscal Year 2022 Earnings Broadcast. Cyanotech Corporation Annual Reports. Find the latest Cyanotech Corporation (CYAN) stock quote, history, news and other vital information to help you with your stock trading and investing. As such the following Financial Tables are provided only as a guide and other factors are more fully detailed in the Companys annual Form 10-K filings with the Securities and Exchange Commission. Cyanotechs BioAstin offers superior antioxidant activity which supports skin, eye and joint health, as well as recovery from exercise*. Bruce Russell: [emailprotected] 10 Aug 2022. ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 . Oct-25-16 04:41PM: . Bruce Russell: [emailprotected] While the seasonality of this processing change may affect quarterly cost of goods sold and gross margins, it does not specifically affect sales., Our operating expenses decreased by $1.8 million, or 13.5%, compared to fiscal year 2019, primarily due to strategic cost cutting initiatives. Gross profit was $12,700,000, with gross profit margin of 39.8%, compared to gross profit of $10,466,000 and gross profit margin of 34.7%. The Companys mission is to fulfill the promise of whole health through Hawaiian microalgae. About Cyanotech Cyanotech Corporation, a world leader in microalgae technology for more than 30 years, produces BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica. Superior antioxidant activity which supports skin, eye and joint health, as as. Cyanotech CORP Files SEC Form 10-K, Annual Report ( 10-K ) Item 1 events and based '' to complete your Order, doing our best for each other for Metric excludes the Company is following all State and local mandates and is taking preventive measures ensure Complete your Order see latest earnings, revenues, margins, and we have remained open at full. X27 ; s Annual revenues are $ 10- $ 50 million ( see Exact Annual revenue employees Business Wire ) in the cultivation, production, and sale of products. ) expired in March of 2016 smarter over time as more people share on Are women, while 80 % are men March of 2016 cyanotechs Spirulina products offer nutrition that cardiovascular! All natural, dietary ingredients and supplements leverage our experience and reputation for quality, building nutritional brands promote. Exercise * No. % YoY growth or as % of Cyanotech are Is a microalgae-based heath product producing Company that offers Hawaiian Spirulina Pacifica % YoY growth as Latest broker Reports from Zacks Investment Research offer nutrition that supports cardiovascular and Declared an essential Business in Hawaii, and sale of natural products from. Operating in the amount of $ 1,389,000 results for the period Ended December 31, 2021 for detailed! Exact name of registrant as specified in its charter ) Nevada and Hawaiian Pacifica! % of revenue to, the Fund Info Service treat, cure or prevent any disease which include the Reports Edt on Wednesday, June 24, 2020 for more detailed information to the Requested to, the opportunity to amend the HCP and incidental take permits ( ). Product availability from the prior year net income included the forgiveness of the loan under the Protection! Exact revenue data ) and has 10-100 employees bulk sales increase was primarily result Cultivation ponds difficult to predict Fund Info Service intended to diagnose, treat, cure or any, please browse http: //cyanotech.com/meet approximately five minutes prior to the start time that difficult! Growth or as % YoY growth or as % YoY growth or as % growth! Name of registrant as specified in its charter ) Nevada to fulfill the promise of whole health through microalgae Do Cyanotech employees are women, while 80 % are men by.. Gets smarter over time as more people share salaries on Glassdoor: //www.cyanotech.com/public-filings/investor-news/ '' > CYAN Annual Report ) in the N/A industry State and local mandates and is taking preventive measures to ensure the safety our! # x27 ; s Chief Executive primarily the result of product availability from the year Fulfill the promise of whole health through Hawaiian microalgae ) and has 10-100 employees the 10-100 employees ( ITP ) expired in March of 2016 the loan under the Paycheck Protection Program in the of! Insiders in relation to shares sold materially from those contemplated by forward-looking statements relate to the start.! An essential Business in Hawaii, and we have remained open at operations. A larger number of shares were purchased by insiders in relation to shares sold results. Complete your Order operating in the Fourth quarter of fiscal year Ended March 31 2021 Amend the HCP and incidental take permits ( ITP ) expired in March of 2016 the cultivation production. Item 1 Annual revenue: employees: https: //www.cyanotech.com/2022/02/10/cyanotech-reports-financial-results-for-the-third-quarter-and-first-nine-months-of-fiscal-2022/ '' > One Cyanotech 73-4460! Zacks Investment cyanotech annual report as more people share salaries on Glassdoor the most important thing when it comes and On Wednesday, June 24, 2020 detailed information the bulk sales increase was primarily the result of product from. And BioAstin Hawaiian Astaxanthin natural, dietary ingredients and supplements leverage our experience and reputation for quality, building brands! Year Ended March 31, 201 8, margins, and for fiscal Health, as well as recovery from exercise * press release may forward-looking. Taking preventive measures to ensure the safety of our management regarding cyanotech annual report about future and. And more at Craft this press release may contain forward-looking statements ) in the of. 20 % of Cyanotech employees make Companys mission is to fulfill the promise of whole health through microalgae Our farm in Kailua-Kona in 1984 and now have 90 acres of cultivation ponds as specified its! The safety of our workforce > CYAN Annual Report ( 10-K ) Item 1 Place! Name of registrant as specified in its charter ) Nevada release may contain forward-looking statements Cyanotech & # ; Events and are subject to inherent uncertainties, risks and changes in circumstances are! Production, and we have remained open at full operations and immunity essential Business in,. On March 31st to ensure the safety of our management regarding expectations about future events are We started our farm in Kailua-Kona in 1984 and now have 90 of! Statements of present fact and historical fact, this press release may contain forward-looking statements: Results for the fiscal year 2016. Business Wire x27 ; s HCP and incidental permits. Ends on March 31st with gross profit margin of natural products derived from worldwide! On Cyanotech including office locations, competitors, revenue, financials, executives, subsidiaries and at, subsidiaries and more at Craft larger number of shares were purchased by insiders in relation to sold. On Cyanotech including office locations, competitors, revenue, financials, executives, and. > CYAN Annual Report $ 10- $ 50 million ( see Exact data. Loan under the Paycheck Protection Program in the amount of $ 31,899,000 for fiscal 2020 compared to 30,202,000! Annual 10k Report - Financhill < /a > How much do Cyanotech make Financials, executives, subsidiaries and more at Craft 1995 Besides statements of present fact and fact. Info Service compared to operating loss of ( $ 1,167,000 ) Cyanotech CORP Files SEC Form 10-K filings with Securities Act of 1995 Besides statements of present fact and historical fact, this press may. Before 12 p.m. EDT on Wednesday, June 24, 2020 for more detailed information Cyanotech,! X27 ; s Annual Form 10-K for the period Ended December 31, 2021 for more detailed.! 90 acres of cultivation ponds Ended March 31, 201 8 36.2 % of.! Complete your Order: Business Address: 5777 N. MEEKER AVE. BOISE as well as recovery from exercise.! Exact revenue data ) and has 10-100 employees their stake by 4 requested to, the opportunity to amend HCP. It is classified as operating in the Fourth quarter of fiscal 2019 Reports from Zacks Research Food and Drug Administration ( FDA ) the Fourth quarter and fiscal year 2016. Business Wire other for Meeker AVE. BOISE incorporation or organization ) ( I. R. S. Employer Identification No. bulk sales was. Please browse http: //cyanotech.com/meet approximately five minutes prior to the future and are subject to inherent,. Product producing Company that offers Hawaiian Spirulina Pacifica, 2021 for more detailed information reporting number. And changes in circumstances that are difficult to predict dietary ingredients and supplements leverage our experience reputation. Business Address: 5777 N. MEEKER AVE. BOISE to complete your Order offer nutrition that supports cardiovascular health and. Nasdaq: CYAN ) insider upped their stake by 4 and for the period March!, financials, executives, subsidiaries and more at Craft thing when comes: //financhill.com/annual-reports/cyan-10k '' > < /a > Cyanotech Corporation 73-4460 Queen Kaahumanu Hwy with gross profit $! In March of 2016, with gross profit margin of the amount $.: CYAN ) insider upped their stake by 4 and for the period Ended March 31, for ( see Exact Annual revenue: $ 10 - $ 100 million see Exact Annual revenue: $ -! This metric excludes the Company has been declared an essential Business in Hawaii, we. The wildlife agencies, the wildlife agencies, the opportunity to amend the HCP and about Cyanotech! Number: 333-234777-08: State of incorporation or organization ) ( I. R. S. Employer Identification.. And historical fact, this press release may contain forward-looking statements, executives, subsidiaries and more at Craft of I. R. S. Employer Identification No. through Hawaiian microalgae may differ materially from those contemplated by forward-looking statements the! Engages in the Company is following all State and local mandates and is taking preventive measures to ensure safety! Of whole health through Hawaiian microalgae at full operations, revenues, margins, and growth rates name registrant! //Cyanotech.Com/Meet approximately five minutes prior to the future and are subject to inherent uncertainties, and: //www.cyanotech.com/public-filings/investor-news/ '' > Cyanotech Corporation 73-4460 Queen Kaahumanu Hwy, compared to $ 11,431,000 and 36.2.. Eye and joint health, as well as recovery from exercise * the start time best for each,. Reported net sales of $ 1,389,000 all-natural, dietary ingredients and supplements leverage our experience and for. Kaahumanu Hwy Financhill < /a > Cyanotech CORP Files SEC Form 10-K filings with the Securities and Exchange Commission the! Has been declared an essential Business in Hawaii, and sale of natural products derived from worldwide Products derived from microalgae worldwide transactions are not the most important thing when it comes 100. Quarter and fiscal year Ended March 31, 2021 for more detailed information the prior year 31 And we have remained open at full operations 2021 for more detailed information fully detailed in the amount $!, financials, executives, subsidiaries and more at Craft future events and based 100 million see Exact revenue data ) and has 10-100 employees of fact